Have a personal or library account? Click to login
Functionality evaluation of co-processed excipients as diluents in tablets manufactured by wet granulation Cover

Functionality evaluation of co-processed excipients as diluents in tablets manufactured by wet granulation

Open Access
|Jan 2021

Figures & Tables

Figure 1

Particle size distribution of LAC (I), LDP (II), SLC (III), MCC (IV), PSV (V), & AVICEL®HFE (VI).
Particle size distribution of LAC (I), LDP (II), SLC (III), MCC (IV), PSV (V), & AVICEL®HFE (VI).

Figure 2

Compressibility plot of (a) Lactose-based formulations, (b) MCC-based formulations.
Compressibility plot of (a) Lactose-based formulations, (b) MCC-based formulations.

Figure 3

Compactibility plot of (a) Lactose-based formulations, (b) MCC-based formulations.
Compactibility plot of (a) Lactose-based formulations, (b) MCC-based formulations.

Figure 4

Tabletability plot of (a) Lactose-based formulations, (b) MCC-based formulations.
Tabletability plot of (a) Lactose-based formulations, (b) MCC-based formulations.

Figure 5

Drug-release profile of Lactose-based formulations.
Drug-release profile of Lactose-based formulations.

Figure 6

Drug-release profile of MCC-based formulations.
Drug-release profile of MCC-based formulations.

Physical properties of metronidazole granules prepared with different diluents_

Formulations with diluents
ParametersIIIIIIIVVVI
Particle size (d50, μm)290.00270.00235.00165.00150.00155.00
Angle of repose (°)30.03 ± 0.2029.63 ± 0.5028.58 ± 1.8730.25 ± 0.6127.52 ± 0.3228.27 ± 0.56
Bulk density (g/cm3)0.55 ± 0.010.54 ± 0.020.48 ± 0.010.43 ± 0.030.43 ± 0.030.41 ± 0.01
Tapped density (g/cm3)0.66 ± 0.020.67 ± 0.000.60 ± 0.010.62 ± 0.070.58 ± 0.010.56 ± 0.02
True density (g/cm3)1.461.441.541.521.521.54
Carr's Index (%)16.44 ± 0.3218.86 ± 3.1019.28 ± 0.3330.95 ± 3.3726.51 ± 2.9225.79 ± 1.83
Hausner's ratio1.20 ± 0.001.23 ± 0.051.24 ± 0.011.45 ± 0.071.36 ± 0.051.35 ± 0.03
Moisture content (%)5.005.005.007.009.008.00

Physical properties of metronidazole tablets prepared using different diluents_

Formulations with diluents
ParametersIIIIIIIVVVI
Mean weight (mg)503.10 ± 26.62507.00 ± 11.41501.80 ± 13.40511.90 ± 15.21509.20 ± 12.84506.00 ± 9.36
Thickness (mm)4.02 ± 0.134.33 ± 0.064.38 ± 0.024.02 ± 0.054.27 ± 0.064.08 ± 0.02
Tensile strength (MPa)0.78 ± 0.120.67 ± 0.300.57 ± 0.051.19 ± 0.110.77 ± 0.041.20 ± 0.23
Friability (%)1.201.952.000.781.10.69
Disintegration time (min)14.01 ± 1.5710.99 ± 1.3910.96 ± 1.0825.40 ± 0.345.77 ± 2.370.32 ± 0.06
T80% (min)18.0015.0014.0030.004.0035.00

Formula for preparing metronidazole granules and tablets (n = 100 tablets)_

Formulations
IngredientsIIIIIIIVVVI
Metronidazole (40%)20.0020.0020.0020.0020.0020.00
Diluent (39%)19.5019.5019.5019.5019.5019.50
Maize starch (10%)5.005.005.005.005.005.00
Acacia (10%)5.005.005.005.005.005.00
CSD (0.5%)0.250.250.250.250.250.25
SSF (0.5%)0.250.250.250.250.250.25
Total (g)50.0050.0050.0050.0050.0050.00
Language: English
Page range: 5 - 14
Submitted on: Jul 29, 2020
|
Accepted on: Jan 8, 2020
|
Published on: Jan 29, 2021
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Related subjects:

© 2021 Y. Eshovo Apeji, IY. Muhammad, A. Kehinde Olowosulu, G. Owoicho Okpanachi, A. Rukayat Oyi, published by Comenius University in Bratislava, Faculty of Pharmacy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.